Connect your AI

Gilead Sciences GILD Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

IncyteINCY

$97.93M+2,923%

ImmunityBio, Inc.IBRX

$971K+341%

PrecigenPGEN

$0+100%

AnaptysBio, Inc.ANAB

$14.02M+4,735%

Iovance Biotherapeutics, Inc.IOVA

$98.51M-33.9%

CelcuityCELC

$206K—

Other financials

Income statement

Revenue$7.0B+4.4%

Gross profit$5.5B+7.6%

Operating income$2.6B+15.6%

Net income$2.0B+53.7%

EPS (diluted)$1.61+54.8%

Balance sheet

Cash & equivalents$7.6B-3.8%

Total debt$22.2B-11.1%

Total equity$23.5B+22.7%

Total assets$56.3B-0.3%

Cash flow

Operating cash flow$2.5B+44.8%

CapEx$117.0M+12.5%

Free cash flow$2.4B+46.8%

Valuation

Market cap$156.86B+21.7%

Enterprise value$171.41B+15.5%

P/E17×-3.4×

P/S5.3×+0.8×

Profitability

Gross margin79.4%+1.1pp

Operating margin34.9%+6.3pp

Net margin31%+10.2pp

FCF margin34.4%+0.1pp

Returns & leverage

Return on equity43.2%+10.7pp

Debt / equity0.9×-0.4×

Current ratio2×+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Gilead Sciences's stock issuance proceeds?: Gilead Sciences (GILD) reported stock issuance proceeds of $166M in Q1 2026.
How has Gilead Sciences's stock issuance proceeds changed year-over-year?: Gilead Sciences's stock issuance proceeds decreased by 34.1% year-over-year, from $252M to $166M.
What is the long-term trend for Gilead Sciences's stock issuance proceeds?: Over 4 years (2021 to 2025), Gilead Sciences's stock issuance proceeds has grown at a 24.7% compound annual growth rate (CAGR), from $169M to $408M.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.